Another strategy employed by Bartlett et al. was to stimulate lysosomal biogenesis and autophagy through gene-transduction of transcription factor EB (TFEB) 26, which has proven benefits in distinct models of cardiac diseases characterized by lysosomal dysfunction 28-31. The gene discussed is TFEB; the disease is heart disorder.